Skandinaviska Enskilda Banken (SEB)
BMY.RT

Skandinaviska Enskilda Banken (SEB)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-716,077
Closed -$495K – 1245
2020
Q4 		$495K Hold
716,077
– – ﹤0.01% 914
2020
Q3 		$1.61M Buy
716,077
+20,000
+3% +$57.1K 0.01% 629
2020
Q2 		$2.49M Hold
696,077
– – 0.02% 496
2020
Q1 		$2.64M Buy
696,077
+69,739
+11% +$230K 0.03% 407
2019
Q4 		$1.89M Buy
+626,338
New +$1.63M 0.01% 573

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s BMY.RT Position: Q1 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 716,077 shares — an estimated $495K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2.64M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 716,077 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $495K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.64M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2021, filed 14 May 2021.